German technical services provider TUV Rheinland’s Indian subsidiary has partnered with Andhra Pradesh MedTech Zone (AMTZ) to create an infrastructure for Electro-Magnetic Interference (EMI/EMC) at an investment of Rs...
Eris Lifesciences IPO opens for subscription
The initial public offer (IPO) of Eris Lifesciences Ltd opened for subscription on Friday, with a price band of Rs600-603 apiece. The Ahmedabad-based company is planning to raise Rs1,741.1 crore through the issue which...
Strides Shasun promoters raise Rs500 crore from KKR
The promoters of Bengaluru-based pharmaceuticals company Strides Shasun Ltd (formerly Strides Arcolab) have raised Rs500 crore from global private equity fund KKR & Co., according to two people aware of the...
Buyout groups lower acceptance threshold for Stada takeover
Buyout groups Bain Capital and Cinven have lowered the minimum acceptance threshold for their takeover offer for German drugmaker Stada’s (STAGn.DE) shares, they said on Wednesday. The tender offer for the agreed...
Stada eyes takeovers of up to 1 billion euros: Welt am Sonntag
German generic drugmaker Stada (STAGn.DE) will be in a position to stem takeovers of up to 1 billion euros ($1.13 billion) thanks to its own acquisition by private equity, Chief Executive Matthias Wiedenfels told German...
France’s Roquette enters Latin America with Brazil tablet maker buy
French plant-based ingredient maker Roquette has agreed to buy pharmaceutical tablet maker Itacel from Brazilian peer Blanver in its first acquisition in a $6 billion global market in which it aims to take a leading...
Pfizer acquires AstraZeneca’s Neksium for Rs 75 crore
US drugmaker Pfizer Inc on Wednesday announced that it has acquired the brand Neksium from Swedish drugmaker AstraZenecaBSE 1.14 % for Rs 75 crore. The attempt is to boost its coverage and equity in the gastro therapy...
Mallinckrodt explores sale of generic drugs business – sources
Mallinckrodt Plc (MNK.N) is exploring a sale of its generic drug unit, in a deal that could fetch as much as $2 billion and help pivot the specialty pharmaceutical maker toward higher-margin branded drugs, according to...
Japanese pharma company Rohto invests $5 million in digital healthcare network Sasta Sundar Healthbuddy
Japanese pharmaceutical company Rohto which started its operations in India in 2010 has tied-up with Sasta Sundar Healthbuddy which is a digital network of healthcare in India running sastasundar.com. Rohto has invested...
Strides Shasun inks JV pact with Vivimed Labs
Drug firm Strides Shasun today said it has inked a pact with Vivimed Labs to set up two joint venture firms. The first JV — a 50:50 joint venture company in India will own a USFDA approved formulation facility in...
Claris Lifesciences to sell 20% stake in JV to partner Otsuka for $20 million
Claris Lifesciences Ltd’s board on Monday approved the sale of its entire 20% stake in a joint venture (JV), Otsuka Pharmaceutical India Pvt. Ltd, to partner Otsuka Pharmaceutical Factory Inc for $20 million. Japanese...
Singh brothers said to seek Rs250/share to sell off Fortis Healthcare
The sale of a controlling stake in hospital chain Fortis Healthcare Ltd and its diagnostics subsidiary SRL Diagnostics Ltd has narrowed to a two-horse race. Private equity funds TPG Capital and General Atlantic Llc are...
